HDAC2 and acute lymphoblastic leukemia: Lastly, HDAC1/HDAC2 targeting has not been efficacious in decreasing the viability of B-NHL cells, in contrast to B-ALL cells, which was confirmed by the absence of H2A histone family member X (H2A.X) upregulation [183].